Literature DB >> 11248075

Peyer's patches are required for oral tolerance to proteins.

K Fujihashi1, T Dohi, P D Rennert, M Yamamoto, T Koga, H Kiyono, J R McGhee.   

Abstract

To clarify the role of Peyer's patches in oral tolerance induction, BALB/c mice were treated in utero with lymphotoxin beta-receptor Ig fusion protein to generate mice lacking Peyer's patches. When these Peyer's patch-null mice were fed 25 mg of ovalbumin (OVA) before systemic immunization, OVA-specific IgG Ab responses in serum and spleen were seen, in marked contrast to low responses in OVA-fed normal mice. Further, high T-cell-proliferative- and delayed-type hypersensitivity responses were seen in Peyer's patch-null mice given oral OVA before systemic challenge. Higher levels of CD4(+) T-cell-derived IFN-gamma, IL-4, IL-5, and IL-10 syntheses were noted in Peyer's patch-null mice fed OVA, whereas OVA-fed normal mice had suppressed cytokine levels. In contrast, oral administration of trinitrobenzene sulfonic acid (TNBS) to Peyer's patch-null mice resulted in reduced TNBS-specific serum Abs and splenic B cell antitrinitrophenyl Ab-forming cell responses after skin painting with picryl chloride. Further, when delayed-type hypersensitivity and splenic T cell proliferative responses were examined, Peyer's patch-null mice fed TNBS were unresponsive to hapten. Peyer's patch-null mice fed trinitrophenyl-OVA failed to induce systemic unresponsiveness to hapten or protein. These findings show that organized Peyer's patches are required for oral tolerance to proteins, whereas haptens elicit systemic unresponsiveness via the intestinal epithelial cell barrier.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11248075      PMCID: PMC30650          DOI: 10.1073/pnas.061412598

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  gammadelta T cells regulate mucosally induced tolerance in a dose-dependent fashion.

Authors:  K Fujihashi; T Dohi; M N Kweon; J R McGhee; T Koga; M D Cooper; S Tonegawa; H Kiyono
Journal:  Int Immunol       Date:  1999-12       Impact factor: 4.823

2.  Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice.

Authors:  P A Koni; R Sacca; P Lawton; J L Browning; N H Ruddle; R A Flavell
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

3.  Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice.

Authors:  M B Alimzhanov; D V Kuprash; M H Kosco-Vilbois; A Luz; R L Turetskaya; A Tarakhovsky; K Rajewsky; S A Nedospasov; K Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 4.  Oral tolerance.

Authors:  T B Tomasi
Journal:  Transplantation       Date:  1980-05       Impact factor: 4.939

5.  Lipopolysaccharide (LPS) regulation of the immune response: LPS converts germfree mice to sensitivity to oral tolerance induction.

Authors:  M J Wannemuehler; H Kiyono; J L Babb; S M Michalek; J R McGhee
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

6.  Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract.

Authors:  M Yamamoto; P Rennert; J R McGhee; M N Kweon; S Yamamoto; T Dohi; S Otake; H Bluethmann; K Fujihashi; H Kiyono
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

7.  Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.

Authors:  C C Whitacre; I E Gienapp; C G Orosz; D M Bitar
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

8.  Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness.

Authors:  T A Banks; B T Rouse; M K Kerley; P J Blair; V L Godfrey; N A Kuklin; D M Bouley; J Thomas; S Kanangat; M L Mucenski
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

9.  Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes.

Authors:  R L Coffman; D A Lebman; B Shrader
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

10.  Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production.

Authors:  E Sonoda; R Matsumoto; Y Hitoshi; T Ishii; M Sugimoto; S Araki; A Tominaga; N Yamaguchi; K Takatsu
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  43 in total

Review 1.  CD40L in autoimmunity and mucosally induced tolerance.

Authors:  Mi-Na Kweon; Hiroshi Kiyono
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Induction of colitis in mice deficient of Peyer's patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches.

Authors:  Thomas W Spahn; Hermann Herbst; Paul D Rennert; Norbert Lügering; Christian Maaser; Mathias Kraft; Adriano Fontana; Howard L Weiner; Wolfram Domschke; Torsten Kucharzik
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Development of organised conjunctival leucocyte aggregates after corneal transplantation in rats.

Authors:  S Banerjee; F C Figueiredo; D L Easty; A D Dick; S M Nicholls
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

Review 4.  Small bowel review: Normal physiology, part 2.

Authors:  Alan B R Thomson; Laurie Drozdowski; Claudiu Iordache; Ben K A Thomson; Severine Vermeire; M Tom Clandinin; Gary Wild
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

5.  Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops.

Authors:  Thomas A Kraus; Jens Brimnes; Christine Muong; Jian-Hua Liu; Thomas M Moran; Kelly A Tappenden; Peter Boros; Lloyd Mayer
Journal:  J Clin Invest       Date:  2005-07-21       Impact factor: 14.808

6.  Importance of gastrointestinal ingestion and macromolecular antigens in the vein for oral tolerance induction.

Authors:  Ayako Wakabayashi; Yoshihiro Kumagai; Eiji Watari; Masumi Shimizu; Masanori Utsuyama; Katsuiku Hirokawa; Hidemi Takahashi
Journal:  Immunology       Date:  2006-06-23       Impact factor: 7.397

7.  T cell-mediated oral tolerance is intact in germ-free mice.

Authors:  K L W Walton; J A Galanko; R Balfour Sartor; N C Fisher
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

Review 8.  Clinical potential of antigen-specific therapies in type 1 diabetes.

Authors:  Ken T Coppieters; Birgit Sehested Hansen; Matthias G von Herrath
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 9.  Trials in type 1 diabetes: Antigen-specific therapies.

Authors:  Ken T Coppieters; Leonard C Harrison; Matthias G von Herrath
Journal:  Clin Immunol       Date:  2013-02-15       Impact factor: 3.969

10.  Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells.

Authors:  Hideaki Suzuki; Shinichi Sekine; Kosuke Kataoka; David W Pascual; Massimo Maddaloni; Ryoki Kobayashi; Keiko Fujihashi; Haruo Kozono; Jerry R McGhee; Kohtaro Fujihashi
Journal:  Gastroenterology       Date:  2008-05-15       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.